The C/EBPd protein is stabilized by estrogen receptor a activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer. (2016)
Attributed to:
Establishment of the Cambridge Single Cell Analysis Clinical Core Facility [SCACCF]
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/onc.2016.156
PubMed Identifier: 27181204
Publication URI: http://europepmc.org/abstract/MED/27181204
Type: Journal Article/Review
Volume: 35
Parent Publication: Oncogene
Issue: 48
ISSN: 0950-9232